Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Recurrence × cemiplimab × Clear all

Phase

Status

Recruiting 2 Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Melanoma 3 Carcinoma, Squamous Cell 3 Lung Neoplasms 2 Resectable Non-small Cell Lung Cancer 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1 Recurrence 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Motor Activity 1 Lymphoma, B-Cell 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioblastoma 1 Cutaneous Squamous Cell Carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Non-small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1 Advanced Malignancies 1

Interventions

Cyclophosphamide 18 Dexamethasone 15 fludarabine 11 Rituximab 7 pomalidomide 6 pembrolizumab 6 fludarabine phosphate 6 daratumumab 6 carfilzomib 6 venetoclax 5 Lenalidomide 5 Gemcitabine 5 Cisplatin 5 Calcium Dobesilate 5 Nivolumab 4 Etoposide 4 Bortezomib 4 isatuximab 3 elotuzumab 3 Vincristine 3 Prednisone 3 Ipilimumab 3 Injections 3 Doxorubicin 3 Carboplatin 3 tisagenlecleucel 2 ruxolitinib 2 obinutuzumab 2 dexamethasone 21-phosphate 2 cabazitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02651662 2026-02-02

CLIO-1

Regeneron Pharmaceuticals

Phase 1 Active not recruiting

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡